ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

TRVI Trevi Therapeutics Inc

2.87
0.23 (8.71%)
Última actualización: 11:03:38
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Trevi Therapeutics Inc TRVI NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.23 8.71% 2.87 11:03:38
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.65 2.57 2.91 2.64
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
09/5/202406:30PRNUSTrevi Therapeutics to Participate in Upcoming Conferences
07/5/202415:09EDGAR2Form 8-K - Current report
07/5/202415:05PRNUSTrevi Therapeutics Reports First Quarter 2024 Financial..
01/5/202415:05PRNUSTrevi Therapeutics to Report First Quarter 2024 Financial..
23/4/202406:30BWFNB Harvest annonce les distributions d’avril 2024
09/4/202406:30PRNUSTrevi Therapeutics Announces Abstract Presentation at the..
04/4/202406:30PRNUSTrevi Therapeutics to Participate in Upcoming April Events
02/4/202406:30PRNUSTrevi Therapeutics Adds Clinical Development Expertise in..
21/3/202406:30BWFNB Harvest annonce les distributions de mars 2024
20/3/202415:05PRNUSTrevi Therapeutics Reports Fourth Quarter and Year End 2023..
13/3/202415:05PRNUSTrevi Therapeutics to Report Q4 and Year End 2023 Financial..
28/2/202406:30PRNUSTrevi Therapeutics to Participate in Upcoming March Events
22/2/202406:30BWFNB Harvest annonce les distributions de février 2024
16/2/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202419:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202414:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202406:30PRNUSTrevi Therapeutics to Participate in the Oppenheimer 34th..
24/1/202406:30BWFNB Harvest annonce les distributions de janvier 2024
04/1/202406:30PRNUSTrevi Therapeutics Provides Business Updates
29/12/202309:26BWFNB Harvest annonce les distributions annuelles finales..
21/12/202315:33BWFNB Harvest Distributions réinvesties annuelles estimatives..
18/12/202306:30BWFNB Harvest annonce les distributions de décembre 2023
05/12/202306:30PRNUSTrevi Therapeutics Announces the Initiation of its Phase 2b..
30/11/202314:14BWFNB Harvest Distributions réinvesties annuelles estimées..
17/11/202306:30BWFNB Harvest annonce les distributions de novembre 2023
09/11/202315:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:08EDGAR2Form 8-K - Current report
09/11/202315:05PRNUSTrevi Therapeutics Announces Third Quarter 2023 Financial..
02/11/202306:30PRNUSTrevi Therapeutics Announces the Initiation of its Phase 2a..
01/11/202315:05PRNUSTrevi Therapeutics to Report Q3 2023 Financial Results and..
17/10/202306:30BWFNB Harvest annonce les distributions d’octobre 2023
13/10/202307:30PRNUSTrevi Therapeutics Announces Results from Phase 2b/3 PRISM..
12/10/202315:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202306:30BWFNB Harvest annonce les distributions de septembre 2023
13/9/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202315:05EDGAR2Form 144 - Report of proposed sale of securities
06/9/202306:30PRNUSTrevi Therapeutics to Participate in Upcoming September..
18/8/202306:30BWFNB Harvest annonce les distributions d'août 2023
15/8/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
14/8/202315:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202315:06EDGAR2Form S-3/A - Registration statement under Securities Act of..
10/8/202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202315:08EDGAR2Form 8-K - Current report
10/8/202315:05PRNUSTrevi Therapeutics Announces Second Quarter 2023 Financial..
03/8/202315:05PRNUSTrevi Therapeutics to Report Q2 2023 Financial Results and..
01/8/202306:30PRNUSTrevi Therapeutics to Participate in Upcoming August Events
19/7/202306:30BWFNB Harvest annonce les distributions d'juillet 2023
12/7/202315:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

Delayed Upgrade Clock